CREDIT AGREEMENT Dated as of September 17, 2019 among VERTEX PHARMACEUTICALS INCORPORATED, as the Company and a Borrower, THE SUBSIDIARIES OF THE COMPANY PARTY HERETO as Designated Foreign Borrowers or Subsidiary Guarantors, BANK OF AMERICA, N.A., as...Credit Agreement • October 31st, 2019 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • New York
The Borrowers hereby acknowledge that, under the Credit Reporting Act 2013 (Ireland), lenders are required to provide personal and credit information for credit applications and credit agreements of €500 and above to the Central Credit Register. This information will be held on the Central Credit Register and may be used by other lenders when making decisions on your credit applications and credit agreements.
AGREEMENT AND PLAN OF MERGER DATED AS OF AUGUST 30, 2019 BY AND AMONG VERTEX PHARMACEUTICALS INCORPORATED, VERTEX DISC INC., SEMMA THERAPEUTICS, INC., AND SHAREHOLDER REPRESENTATIVE SERVICES LLC,Agreement and Plan of Merger • October 31st, 2019 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of August 30, 2019 by and among Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (“Purchaser”), Vertex Disc Inc., a Delaware corporation and a wholly owned Subsidiary of Purchaser (“Merger Sub”), Semma Therapeutics, Inc., a Delaware corporation (the “Company”), and Shareholder Representative Services LLC, a Colorado limited liability company (“Representative”), solely in its capacity as agent for the Equityholders. Purchaser, Merger Sub, the Company and Representative are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
